These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17895942)

  • 41. Exposure to oxygen and head growth in infants with bronchopulmonary dysplasia.
    Nesterenko TH; Nolan B; Hammad TA; Aly H
    Am J Perinatol; 2008 Apr; 25(4):251-4. PubMed ID: 18548401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.
    Capoluongo E; Ameglio F; Lulli P; Minucci A; Santonocito C; Concolino P; Di Stasio E; Boccacci S; Vendettuoli V; Giuratrabocchetta G; De Cunto A; Tana M; Romagnoli C; Zuppi C; Vento G
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E308-13. PubMed ID: 16954333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth factors, stem cells and bronchopulmonary dysplasia.
    Alphonse RS; Thébaud B
    Neonatology; 2011; 99(4):326-37. PubMed ID: 21701205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence?
    Thomas W; Speer CP
    Neonatology; 2008; 94(3):150-9. PubMed ID: 18679037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating "old" definitions for the "new" bronchopulmonary dysplasia.
    Davis PG; Thorpe K; Roberts R; Schmidt B; Doyle LW; Kirpalani H;
    J Pediatr; 2002 May; 140(5):555-60. PubMed ID: 12032521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia.
    Baveja R; Christou H
    Semin Perinatol; 2006 Aug; 30(4):209-18. PubMed ID: 16860161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.
    Nowadzky T; Pantoja A; Britton JR
    Pediatrics; 2009 Jun; 123(6):1534-40. PubMed ID: 19482765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia.
    May C; Williams O; Milner AD; Peacock J; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F205-9. PubMed ID: 19383857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of infants with bronchopulmonary dysplasia in Germany.
    Thomas W; Speer CP
    Early Hum Dev; 2005 Feb; 81(2):155-63. PubMed ID: 15748970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ureaplasma urealyticum: no independent role in the pathogenesis of bronchopulmonary dysplasia.
    Aaltonen R; Vahlberg T; Lehtonen L; Alanen A
    Acta Obstet Gynecol Scand; 2006; 85(11):1354-9. PubMed ID: 17091417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Research advance in prevention and treatment of bronchopulmonary dysplasia in premature infants].
    Xuan Z; Xue XD; Fu JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):412-6. PubMed ID: 20497659
    [No Abstract]   [Full Text] [Related]  

  • 54. Abnormal oral mucosal light reflectance in bronchopulmonary dysplasia.
    De Felice C; Parrini S; Barducci A; Chitano G; Tonni G; Latini G
    Early Hum Dev; 2006 Apr; 82(4):273-8. PubMed ID: 16338107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term pulmonary outcome in the preterm infant.
    Greenough A
    Neonatology; 2008; 93(4):324-7. PubMed ID: 18525217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA; Harrison M; Clark RH
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ureaplasma and bronchopulmonary dysplasia.
    Gancia P; Delogu A; Pomero G
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S39-41. PubMed ID: 24709455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal strategies for newborn ventilation--a synthesis of the evidence.
    Greenough A; Sharma A
    Early Hum Dev; 2005 Dec; 81(12):957-64. PubMed ID: 16278057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized trial of delayed extubation for the reduction of reintubation in extremely preterm infants.
    Danan C; Durrmeyer X; Brochard L; Decobert F; Benani M; Dassieu G
    Pediatr Pulmonol; 2008 Feb; 43(2):117-24. PubMed ID: 18092355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.